IRIS Accounts Production v24.1.4.33 SC467226 Board of Directors Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false 75000 256246 356246 75000 25000 75000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC4672262023-03-31SC4672262024-03-31SC4672262023-04-012024-03-31SC4672262022-03-31SC4672262022-04-012023-03-31SC4672262023-03-31SC467226ns15:Scotland2023-04-012024-03-31SC467226ns14:PoundSterling2023-04-012024-03-31SC467226ns10:Director12023-04-012024-03-31SC467226ns10:Director22023-04-012024-03-31SC467226ns10:PrivateLimitedCompanyLtd2023-04-012024-03-31SC467226ns10:SmallEntities2023-04-012024-03-31SC467226ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-31SC467226ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-31SC467226ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-31SC467226ns10:FullAccounts2023-04-012024-03-31SC46722642ns10:Director22023-03-31SC46722642ns10:Director22022-03-31SC46722642ns10:Director22022-04-012023-03-31SC46722642ns10:Director22023-04-012024-03-31SC46722642ns10:Director22023-03-31SC467226ns10:RegisteredOffice2023-04-012024-03-31SC467226ns5:CurrentFinancialInstruments2024-03-31SC467226ns5:CurrentFinancialInstruments2023-03-31SC467226ns5:ShareCapital2024-03-31SC467226ns5:ShareCapital2023-03-31SC467226ns5:FurtherSpecificReserve3ComponentTotalEquity2024-03-31SC467226ns5:FurtherSpecificReserve3ComponentTotalEquity2023-03-31SC467226ns5:RetainedEarningsAccumulatedLosses2024-03-31SC467226ns5:RetainedEarningsAccumulatedLosses2023-03-31SC467226ns5:ListedExchangeTradedns5:CostValuation2023-03-31SC467226ns5:ListedExchangeTradedns5:AdditionsToInvestments2024-03-31SC467226ns5:ListedExchangeTradedns5:RevaluationsIncreaseDecreaseInInvestments2024-03-31SC467226ns5:ListedExchangeTradedns5:CostValuation2024-03-31SC467226ns5:ListedExchangeTraded2024-03-31SC467226ns5:ListedExchangeTraded2023-03-31SC467226ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-31SC467226ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-31SC4672261ns10:Director12023-03-31SC4672261ns10:Director12022-03-31SC4672261ns10:Director12023-04-012024-03-31SC4672261ns10:Director12022-04-012023-03-31SC4672261ns10:Director12024-03-31SC4672261ns10:Director12023-03-31
REGISTERED NUMBER: SC467226 (Scotland)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024

FOR

ANLAGEN LIMITED

ANLAGEN LIMITED (REGISTERED NUMBER: SC467226)

CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 March 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


ANLAGEN LIMITED

COMPANY INFORMATION
for the year ended 31 March 2024







DIRECTORS: Dr S J Richards
Ms H Buckmayer



REGISTERED OFFICE: 24A Ainslie Place
Edinburgh
Midlothian
EH3 6AJ



REGISTERED NUMBER: SC467226 (Scotland)



ACCOUNTANTS: Mitchell Edwards
Chartered Certified Accountants
24A Ainslie Place
Edinburgh
EH3 6AJ



BANKERS: Bank of Scotland
8 Morningside Road
Edinburgh
EH10 5QF

ANLAGEN LIMITED (REGISTERED NUMBER: SC467226)

BALANCE SHEET
31 March 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Investments 4 6,126,346 4,758,694

CURRENT ASSETS
Debtors 5 48 75,000
Cash at bank 42,822 211,372
42,870 286,372
CREDITORS
Amounts falling due within one year 6 4,424,762 4,069,973
NET CURRENT LIABILITIES (4,381,892 ) (3,783,601 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,744,454

975,093

PROVISIONS FOR LIABILITIES 131,043 3,729
NET ASSETS 1,613,411 971,364

CAPITAL AND RESERVES
Called up share capital 2 2
Fair value reserve 1,063,099 504,443
Retained earnings 550,310 466,919
SHAREHOLDERS' FUNDS 1,613,411 971,364

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 16 August 2024 and were signed on its behalf by:




Dr S J Richards - Director



Ms H Buckmayer - Director


ANLAGEN LIMITED (REGISTERED NUMBER: SC467226)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 March 2024


1. STATUTORY INFORMATION

Anlagen Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£), rounded to the nearest £.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

The company meets its day to day working capital requirements through Intercompany loans. They will continue to support the company until sufficient profitability is achieved and on this basis consider it appropriate to prepare the accounts on a going concern basis.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Listed investments
Fixed asset investments are initially recognised at their transaction value and subsequently measured at their fair value at the balance sheet date using the closing quoted market price. The Income Statement includes the net gains and losses arising on revaluations and disposals throughout the year.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

ANLAGEN LIMITED (REGISTERED NUMBER: SC467226)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2024


4. FIXED ASSET INVESTMENTS
Listed
investments
£   
COST OR VALUATION
At 1 April 2023 4,758,694
Additions 677,954
Revaluations 689,698
At 31 March 2024 6,126,346
NET BOOK VALUE
At 31 March 2024 6,126,346
At 31 March 2023 4,758,694

Cost or valuation at 31 March 2024 is represented by:

Listed
investments
£   
Valuation in 2018 (20,289 )
Valuation in 2019 5,320
Valuation in 2020 (661,679 )
Valuation in 2021 1,016,249
Valuation in 2022 243,254
Valuation in 2023 19,627
Valuation in 2024 689,698
Cost 4,834,166
6,126,346

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 48 75,000

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security - 381
Other creditors 4,424,762 4,069,592
4,424,762 4,069,973

ANLAGEN LIMITED (REGISTERED NUMBER: SC467226)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2024


7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2024 and 31 March 2023:

2024 2023
£    £   
Dr S J Richards and Ms H Buckmayer
Balance outstanding at start of year 75,000 (256,246 )
Amounts advanced - 356,246
Amounts repaid (75,000 ) (25,000 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - 75,000

8. RELATED PARTY DISCLOSURES

Included in Other creditors is a loan due to its parent company amounting to £4,421,300 (2023: £4,067,000). The loan is unsecured, interest free and repayable on demand.